Great West Life Assurance CO Altimmune, Inc. Transaction History

Great West Life Assurance CO

  • $58 Billion
  • Q4 2024

A detailed history of Great West Life Assurance CO transactions in Altimmune, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 4,354 shares of ALT stock, worth $27,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,354
Previous 4,354 -0.0%
Holding current value
$27,734
Previous $27,000 14.81%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$8.22 - $13.81 $35,789 - $60,128
4,354 New
4,354 $44,000
Q4 2022

Feb 10, 2023
BUY
$8.74 - $16.45 $21,544 - $40,549
2,465 New
2,465 $41,000

Others Institutions Holding ALT

# of Institutions
208
Shares Held
39.5M
Call Options Held
1.94M
Put Options Held
1.38M
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $312M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email